Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An Update on mRNA-Based Viral Vaccines
Subbiah Jeeva, Ki‐Hye Kim, Chong Hyun Shin, et al.
Vaccines (2021) Vol. 9, Iss. 9, pp. 965-965
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Computational biology and artificial intelligence in mRNA vaccine design for cancer immunotherapy
Saber İmani, Xiaoyan Li, Keyi Chen, et al.
Frontiers in Cellular and Infection Microbiology (2025) Vol. 14
Open Access | Times Cited: 5
Vaccines for COVID-19: A Systematic Review of Immunogenicity, Current Development, and Future Prospects
Zhan Zhang, Qi Shen, Haocai Chang
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 58
mRNA-Based Vaccine for COVID-19: They Are New but Not Unknown!
Vivek P. Chavda, Gargi Jogi, Srusti Dave, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 507-507
Open Access | Times Cited: 33
Strand-Cleaving Deoxyribozymes Enable the Mid-Down Sequencing of mRNA by Mass Spectrometry with No Front-End Separations
Sarah G. Mutchek, Thomas Kenderdine, Kevin B. Turner, et al.
Analytical Chemistry (2025) Vol. 97, Iss. 5, pp. 2972-2980
Closed Access | Times Cited: 1
mRNA Therapeutic Modalities Design, Formulation and Manufacturing under Pharma 4.0 Principles
Andreas Ouranidis, Theofanis Vavilis, Evdokia Mandala, et al.
Biomedicines (2021) Vol. 10, Iss. 1, pp. 50-50
Open Access | Times Cited: 47
Challenges and emerging trends in liquid chromatography-based analyses of mRNA pharmaceuticals
Szabolcs Fekete, Catalin E. Doneanu, Balasubrahmayam Addepalli, et al.
Journal of Pharmaceutical and Biomedical Analysis (2022) Vol. 224, pp. 115174-115174
Open Access | Times Cited: 37
Characterization of mRNA therapeutics
Guilherme J. Guimaraes, Jaeah Kim, Michael G. Bartlett
Mass Spectrometry Reviews (2023) Vol. 43, Iss. 5, pp. 1066-1090
Open Access | Times Cited: 18
In Vitro Transcribed RNA-Based Platform Vaccines: Past, Present, and Future
Alexey D. Perenkov, Alena D. Sergeeva, Maria V. Vedunova, et al.
Vaccines (2023) Vol. 11, Iss. 10, pp. 1600-1600
Open Access | Times Cited: 13
Design of a Multiepitope Pan‐Proteomic mRNA Vaccine Construct Against African Swine Fever Virus: A Reverse Vaccinology Approach
Ella Mae Joy S. Sira, Lauren Emily Fajardo, Edward C. Banico, et al.
Veterinary Medicine International (2025) Vol. 2025, Iss. 1
Open Access
mRNA vaccines: The new frontier
Zhipeng Yan, Ming Yang, E Tian, et al.
Elsevier eBooks (2025), pp. 669-683
Closed Access
Technological breakthroughs and advancements in the application of mRNA vaccines: a comprehensive exploration and future prospects
Zijing Wei, Shuai Zhang, Xingya Wang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
The Bright Future of mRNA as a Therapeutic Molecule
Dora Emma Vélez, Blanca Licia Torres, Greco Hernández
Genes (2025) Vol. 16, Iss. 4, pp. 376-376
Open Access
Enhancing the Effect of Nucleic Acid Vaccines in the Treatment of HPV-Related Cancers: An Overview of Delivery Systems
Ingrid Andrêssa de Moura, Anna Jéssica Duarte Silva, Larissa Silva de Macêdo, et al.
Pathogens (2022) Vol. 11, Iss. 12, pp. 1444-1444
Open Access | Times Cited: 17
Comparison of capillary electrophoresis-based methods for the analytical characterization of purity and stability of in vitro transcribed mRNA
Prerana Mantri, Bindiya Juneja, Steven Henderson, et al.
Journal of Pharmaceutical and Biomedical Analysis (2024) Vol. 249, pp. 116352-116352
Open Access | Times Cited: 3
Implementation of mRNA–Lipid Nanoparticle Technology in Atlantic Salmon (Salmo salar)
Lars Ole Sti Dahl, Sjoerd Hak, Stine Braaen, et al.
Vaccines (2024) Vol. 12, Iss. 7, pp. 788-788
Open Access | Times Cited: 3
Vaccines against SARS-CoV-2 variants and future pandemics
Taeyoung Park, Hyogyeong Hwang, Suhyeong Moon, et al.
Expert Review of Vaccines (2022) Vol. 21, Iss. 10, pp. 1363-1376
Open Access | Times Cited: 16
A new H9 influenza virus mRNA vaccine elicits robust protective immunity against infection
Shengkui Xu, Bowen Zhang, Jielin Yao, et al.
Vaccine (2023) Vol. 41, Iss. 18, pp. 2905-2913
Closed Access | Times Cited: 8
Recent Advances in Messenger Ribonucleic Acid (mRNA) Vaccines and Their Delivery Systems: A Review
Wubetu Yihunie, Getinet Nibret, Yibeltal Aschale
Clinical Pharmacology Advances and Applications (2023) Vol. Volume 15, pp. 77-98
Open Access | Times Cited: 7
Implementation of the mRNA-Lipid Nanoparticle Technology in Atlantic Salmon (Salmo salar)
Lars Ole Sti Dahl, Sjoerd Hak, Stine Braaen, et al.
(2024)
Open Access | Times Cited: 2
Separation of oligonucleotides by ion-exchange and ion-pair chromatography
Michael G. Bartlett
Elsevier eBooks (2024), pp. 413-434
Closed Access | Times Cited: 1
Identification of tumor-associated antigens and immune subtypes of lower-grade glioma and glioblastoma for mRNA vaccine development
Zhiliang Wang, Ruoyu Huang, Bo Han, et al.
Chinese Neurosurgical Journal (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 6
Artificial Intelligence-Mediated Computer-Aided Design of Viral Gene Therapies
Alireza Daneshvar, Stefan Lukianov
GEN Biotechnology (2023) Vol. 2, Iss. 6, pp. 482-489
Closed Access | Times Cited: 2
Do Messenger RNA Vaccines Induce Pathological Syncytia?
Sfera Adonis, Thomas Karina G, Sfera DAN O, et al.
International Journal of Pathology and Clinical Research (2022) Vol. 8, Iss. 2
Open Access | Times Cited: 4
The association between influenza vaccine effectiveness and egg-based manufacturing technology: literature review and US expert consensus
Archana Chatterjee, Karita Ambrose, David H. Canaday, et al.
Current Medical Research and Opinion (2023) Vol. 40, Iss. 2, pp. 335-343
Open Access | Times Cited: 1
The MSH3 Gene From A Neuropsychiatrist’s Perspective
Adonis Sfera, Dan O Sfera, Sarvin Sasannia, et al.
Advances In Clinical And Medical Research (2022) Vol. 3, Iss. 4, pp. 01-09
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top